HealthEquity shares fell 10.2% following the release of 2027 guidance that fell short of market expectations. Management forecasted revenue of $1.38 billion to $1.41 billion in fiscal 2027, below the consensus projection of $1.45 billion. EBITDA margin guidance of 43.8% to 44.3% also trailed street estimates by roughly 150 basis points. The reaction reflects investor sensitivity to any deceleration in the company’s historical growth trajectory, despite solid fundamentals in its core business.

HealthEquity reported robust growth in its health savings account (HSA) platform, serving more than 17 million accounts and stewarding over $34 billion in HSA assets. During the latest quarter, new account openings increased 12% year-over-year and average assets per account rose to $2,035, up 8% from the prior year. These metrics drove 22% revenue growth in the HSA segment, underpinning consistent margin expansion and free cash flow generation that supported a 16% year-over-year increase in operating income.

In a presentation at the J.P. Morgan Healthcare Conference, CEO Scott Cutler emphasized the company’s transition to a modernized platform following his appointment one year ago. He highlighted a disciplined execution playbook focused on strengthening infrastructure, enhancing member engagement and scaling technology capabilities. CFO Jim Lucania reaffirmed the company’s commitment to operating margin improvement, targeting a 200-basis-point uplift through cost efficiencies and cross-sell initiatives within the existing client base.